BeStock  
Stocks › Biotechnology › SPTX

Seaport Therapeutics SPTX

US equityMarket cap rank #3270Biotechnology
$17.93 +$0.56 (+3.22%)
Pre-market · Oct 8, 9:10 am ET · After hours $17.93 0.00%
Open$17.28
Prev close$17.37
Day range$17.07 – $18.29
Volume249.1K
Market cap$959.80M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership102.2%+0.12 pts vs. prior quarter
Institutions holding62+1 vs. prior quarter
Insider trades (recent)19 buys / 0 sellsNet buying
Short interest5.88% of floatDays to cover 20.7 · as of 15 Sep 2026
Short-sale volume share26.9%5-day average of daily volume

Short-sale volume as % of daily volume

12%28%45%62%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$68.0K (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

−$148.0KSuper+$80.0KBig+$198.1KMid+$1.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 64.8% of shares outstanding.

Largest holders

  • PureTech Health plc31.17%
  • Arch Venture Partners, L.P.11.76%
  • General Atlantic Service Company, L.P.11.40%
  • Sofinnova Investments, Inc.6.66%
  • Third Rock Ventures, LLC3.85%
  • Canada Pension Plan Investment Board3.69%
  • J.P. Morgan Asset Management, Inc.3.33%
  • Foresite Capital Management, LLC3.32%

By investor type

  • VC/PE Fund41.28%
  • Public Company33.49%
  • Mutual Fund19.49%
  • Individual/Insider4.58%
  • Government Pension Fund3.69%
  • Hedge Fund3.53%
  • Sovereign Wealth Fund0.64%
  • Private Company0.02%

Reported short interest has risen from 5.19% to 5.88% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
PureTech Health plc Public Company 2026/Q3 +16,685,013 31.2%
Arch Venture Partners, L.P. VC/PE Fund 2026/Q3 +6,294,951 11.8%
General Atlantic Service Company, L.P. VC/PE Fund 2026/Q3 +6,101,582 11.4%
Sofinnova Investments, Inc. VC/PE Fund 2026/Q3 +3,564,871 6.7%
Third Rock Ventures, LLC VC/PE Fund 2026/Q3 +2,061,222 3.9%
Canada Pension Plan Investment Board Government Pension Fund 2026/Q3 +1,975,791 3.7%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +1,785,104 3.3%
Foresite Capital Management, LLC VC/PE Fund 2026/Q3 +1,779,521 3.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,308,604 2.4%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,194,858 2.2%
Daphne Zohar Individual/Insider 2026/Q3 +1,194,001 2.2%
FMR Mutual Fund 2026/Q3 +1,185,100 2.2%
Bellevue Asset Management AG Mutual Fund 2026/Q3 +1,100,000 2.1%
Artal Group S.A. VC/PE Fund 2026/Q3 +1,095,316 2.0%
Jennison Associates LLC Mutual Fund 2026/Q3 +1,079,669 2.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
21 Jun 2026 Robert Hombach Independent Director Open Market Acquisition +13,000 $18.14 13,000
3 May 2026 General Atlantic Service Company, L.P. Initial Statement of Beneficial +0 – 6,101,582
3 May 2026 Steven Paul Founder & Non-Employee Chair of the Board Derivative Exercise and Retained +67,031 – 863,031
3 May 2026 PureTech Health plc Derivative Exercise and Retained +16,382,534 – 16,685,013
3 May 2026 Antony Loebel Chief Medical Officer & President of Clinical Development Derivative Exercise and Retained +20,109 – 20,109
3 May 2026 Denice Torres Independent Director Derivative Exercise and Retained +13,406 – 13,406
3 May 2026 Lana Gladstein General Counsel Derivative Exercise and Retained +33,515 – 33,515
3 May 2026 Lauren White Chief Financial Officer Derivative Exercise and Retained +6,702 – 6,702
3 May 2026 Michael Chen Co-Founder & CSO Derivative Exercise and Retained +3,351 – 3,351
29 Apr 2026 Sandra Peterson Independent Director Other Derivative Acquisition +12,258 $18.00 12,258
29 Apr 2026 Sandra Peterson Independent Director Initial Statement of Beneficial +0 – 89,300
29 Apr 2026 Sharon Mates Independent Director Other Derivative Acquisition +49,033 $18.00 49,033
29 Apr 2026 Steven Paul Founder & Non-Employee Chair of the Board Other Derivative Acquisition +1,003,450 $18.00 991,192
29 Apr 2026 Steven Paul Founder & Non-Employee Chair of the Board Initial Statement of Beneficial +0 – 1,674,753
29 Apr 2026 PureTech Health plc Initial Statement of Beneficial +0 – 302,479
29 Apr 2026 Daphne Zohar Chief Executive Officer Other Derivative Acquisition +1,758,599 $18.00 1,486,786
29 Apr 2026 Daphne Zohar Chief Executive Officer Initial Statement of Beneficial +0 – 2,765,557
29 Apr 2026 Robert Hombach Independent Director Other Derivative Acquisition +12,258 $18.00 12,258
29 Apr 2026 Robert Hombach Independent Director Initial Statement of Beneficial +0 – 89,300
29 Apr 2026 David Wheadon Independent Director Other Derivative Acquisition +12,258 $18.00 12,258

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 3,148,881 5.9% 20.7
31 Aug 2026 3,152,409 5.9% 26.0
14 Aug 2026 3,012,877 5.6% 25.1
31 Jul 2026 2,758,029 5.2% 30.8
15 Jul 2026 1,980,276 3.7% 12.3
30 Jun 2026 2,779,385 5.2% 7.7

Discussion

No comments yet — be the first to weigh in on SPTX.

Leave a comment

Scroll to Top